Our top pick for
Proofpoint, Inc is a software-infrastructure business based in the US. Proofpoint shares (PFPT) are listed on the NASDAQ and all prices are listed in US Dollars.
|52-week range||USD$83.81 - USD$140.91|
|50-day moving average||USD$134.17|
|200-day moving average||USD$115.0998|
|Wall St. target price||USD$150|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||USD$-2.1|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Valuing Proofpoint stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Proofpoint's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Proofpoint's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.7508. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Proofpoint's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Proofpoint's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$769,000.
The EBITDA is a measure of a Proofpoint's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||USD$1.1 billion|
|Gross profit TTM||USD$774.6 million|
|Return on assets TTM||-2.46%|
|Return on equity TTM||-31.68%|
|Market capitalisation||USD$7.2 billion|
TTM: trailing 12 months
There are currently 1.8 million Proofpoint shares held short by investors – that's known as Proofpoint's "short interest". This figure is 1.4% down from 1.9 million last month.
There are a few different ways that this level of interest in shorting Proofpoint shares can be evaluated.
Proofpoint's "short interest ratio" (SIR) is the quantity of Proofpoint shares currently shorted divided by the average quantity of Proofpoint shares traded daily (recently around 500685.86956522). Proofpoint's SIR currently stands at 3.68. In other words for every 100,000 Proofpoint shares traded daily on the market, roughly 3680 shares are currently held short.
However Proofpoint's short interest can also be evaluated against the total number of Proofpoint shares, or, against the total number of tradable Proofpoint shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Proofpoint's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 Proofpoint shares in existence, roughly 30 shares are currently held short) or 0.0384% of the tradable shares (for every 100,000 tradable Proofpoint shares, roughly 38 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Proofpoint.
Find out more about how you can short Proofpoint stock.
We're not expecting Proofpoint to pay a dividend over the next 12 months.
Over the last 12 months, Proofpoint's shares have ranged in value from as little as $83.81 up to $140.91. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Proofpoint's is 1.1638. This would suggest that Proofpoint's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Proofpoint, Inc. operates as a security-as-a-service provider that enables large and mid-sized organizations to defend, protect, archive, and govern their sensitive data worldwide. It offers protection against advanced and targeted threats, including malicious attachments, polymorphic threats, zero-day exploits, user-transparent ?drive-by' downloads, malicious web links, hybrid threats, malware free attacks, and other penetration tactics. The company also provides integrated email security, cloud security, advanced threat, information protection and archiving, and digital risk protection product services. In addition, it offers solutions that enable secure business-to-business and business-to-consumer communications; email encryption services that encrypt sensitive emails and deliver them to PC or mobile device; file-transfer solutions for end-users to share various forms of documents and other content; security optimized cloud architecture solutions; and extensible security-as-a-service platform. The company serves aerospace and defense, education, financial services, government, healthcare, manufacturing, and retail sectors. Proofpoint, Inc. was founded in 2002 and is headquartered in Sunnyvale, California.
Everything we know about the Toast Inc IPO, plus information on how to buy in.
Everything we know about the Cyxtera IPO, plus information on how to buy in.
Everything we know about the ATI Physical Therapy IPO, plus information on how to buy in.
Everything we know about the Sportradar IPO, plus information on how to buy in.
Everything we know about the Longboard Pharmaceuticals Inc IPO, plus information on how to buy in.
Everything we know about the Prometheus Biosciences Inc IPO, plus information on how to buy in.
Everything we know about the Olo Inc IPO, plus information on how to buy in.
Everything we know about the China Eco-Materials Group Co Limited IPO, plus information on how to buy in.
Everything we know about the Gain Therapeutics Inc IPO, plus information on how to buy in.
Everything we know about the Karat Packaging Inc IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.